Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH), 9254-9255 [2012-3587]

Download as PDF 9254 Federal Register / Vol. 77, No. 32 / Thursday, February 16, 2012 / Notices accessed through AHRQ’s PSO Web site at https://www.pso.AHRQ.GOV/formats/ commonfmt.htm. AHRQ is committed to continuing refinement of the Common Formats, and welcomes questions from prospective meeting participants and interested individuals on the technical specifications. These questions should be emailed to support@psoppc.ORG no later than March 21, 2012. AHRQ will use the input received at this meeting to further update and refine the Common Formats. A summary of the meeting will be provided upon request. If you are unable to participate in the meeting and would like a copy of the summary, please send an email to supportpsoppc.ORG and it will be sent as soon as it is available after the meeting. Dated: January 25, 2012. Carolyn M. Clancy, Director. [FR Doc. 2012–2937 Filed 2–15–12; 8:45 am] BILLING CODE 4160–90–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention srobinson on DSK4SPTVN1PROD with NOTICES Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), and pursuant to the requirements of 42 CFR 83.15(a), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Board Public Meeting Times and Dates (All times are Pacific Time): 9:45 a.m.–5 p.m., February 28, 2012. 8:15 a.m.–6 p.m., February 29, 2012. Public Comment Times and Dates (All times are Pacific Time): 5 p.m.–6:30 p.m.,* February 28, 2012. * Please note that the public comment periods may end before the times indicated, following the last call for comments. Members of the public who wish to provide public comments should plan to attend public comment sessions at the start times listed. Place: Waterfront Hotel, 10 Washington Street, Oakland, California 94607, Telephone: (510) 836–3800, Fax: (510) 832–5695, Audio Conference Call via FTS Conferencing, the USA toll-free number is 1–866–659–0537 with a pass code of 9933701. VerDate Mar<15>2010 16:31 Feb 15, 2012 Jkt 226001 Status: Open to the public, limited only by the space available. The meeting space accommodates approximately 150 people. Background: The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Advisory Board include providing advice on the development of probability of causation guidelines which have been promulgated by the Department of Health and Human Services (HHS) as a final rule, advice on methods of dose reconstruction which have also been promulgated by HHS as a final rule, advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program, and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the Advisory Board to HHS, which subsequently delegated this authority to the CDC. NIOSH implements this responsibility for CDC. The charter was issued on August 3, 2001, renewed at appropriate intervals, and will expire on August 3, 2013. Purpose: This Advisory Board is charged with (a) providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, advise the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. Matters To Be Discussed: The agenda for the Advisory Board meeting includes: NIOSH Program Update; Department of Labor (DOL) Program Update; Department of Energy (DOE) Program Update; NIOSH 10-Year Program Review Implementation; Status of Activities for Lawrence Berkeley National Laboratory and Stanford Linear Accelerator; SEC petitions for: Electro Metallurgical (Niagara Falls, NY), Hangar 481 (Kirtland Air Force Base); Weldon Spring Plant (Weldon Spring, MO), Sandia National Laboratories, PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 Clinton Engineering Works (Oak Ridge, TN), Feed Materials Production Center (Fernald, Ohio), and Brookhaven National Laboratory; SEC Petition Status Updates; and Board Work Sessions. The agenda is subject to change as priorities dictate. In the event an individual cannot attend, written comments may be submitted in accordance with the redaction policy provided below. Any written comments received will be provided at the meeting and should be submitted to the contact person below well in advance of the meeting. Policy on Redaction of Board Meeting Transcripts (Public Comment): (1) If a person making a comment gives his or her name, no attempt will be made to redact that name. (2) NIOSH will take reasonable steps to ensure that individuals making public comment are aware of the fact that their comments (including their name, if provided) will appear in a transcript of the meeting posted on a public Web site. Such reasonable steps include: (a) A statement read at the start of each public comment period stating that transcripts will be posted and names of speakers will not be redacted; (b) A printed copy of the statement mentioned in (a) above will be displayed on the table where individuals sign up to make public comments; (c) A statement such as outlined in (a) above will also appear with the agenda for a Board Meeting when it is posted on the NIOSH Web site; (d) A statement such as in (a) above will appear in the Federal Register Notice that announces Board and Subcommittee meetings. (3) If an individual in making a statement reveals personal information (e.g., medical information) about themselves that information will not usually be redacted. The NIOSH FOIA coordinator will, however, review such revelations in accordance with the Freedom of Information Act and the Federal Advisory Committee Act and if deemed appropriate, will redact such information. (4) All disclosures of information concerning third parties will be redacted. (5) If it comes to the attention of the DFO that an individual wishes to share information with the Board but objects to doing so in a public forum, the Designated Federal Officer will work with that individual, in accordance with the Federal Advisory Committee Act, to find a way that the Board can hear such comments. Contact Person for More Information: Theodore Katz, M.P.A., Executive Secretary, NIOSH, CDC, 1600 Clifton Road NE., MS E–20, Atlanta, Georgia 30333, Telephone: (513) 533–6800, toll E:\FR\FM\16FEN1.SGM 16FEN1 Federal Register / Vol. 77, No. 32 / Thursday, February 16, 2012 / Notices free: 1–800–CDC–INFO, email: dcas@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: February 7, 2012. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2012–3587 Filed 2–15–12; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS–1594–N] Medicare Program: Notice of Six Membership Appointments to the Advisory Panel on Hospital Outpatient Payment Centers for Medicare & Medicaid Services (CMS), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: This notice announces six new membership appointments to the Advisory Panel on Hospital Outpatient Payment (HOP, the Panel). The six appointments to the 19 member Panel will each serve a 4-year period. Five of the new members will have terms that begin on February 1, 2012 and continuing through January 31, 2016. The sixth member’s term will begin on August 1, 2012 and continuing through July 31, 2016. The purpose of the Panel is to advise the Secretary of the Department of Health and Human Services and the Administrator of the Centers for Medicare & Medicaid Services concerning the clinical integrity of the Ambulatory Payment Classification groups and their weights. The Panel also addresses and makes recommendations regarding supervision of outpatient services. The advice provided by the Panel will be considered as we prepare the annual updates for the hospital outpatient prospective payment system. FOR FURTHER INFORMATION CONTACT: For additional information on the Panel meeting dates, agenda topics, copy of the charter, as well as updates to the Panel’s activities, search our Internet srobinson on DSK4SPTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 16:31 Feb 15, 2012 Jkt 226001 Web site: https://www.cms.gov/FACA/ 05_AdvisoryPanelonAmbulatory PaymentClassification Groups.asp#TopOfPage. (Note: There is an UNDERSCORE after FACA/05_; there is no space.) For other information regarding the Panel, contact Paula Smith, the Designated Federal Officer at CMS, Center for Medicare, Hospital and Ambulatory Policy Group, Division of Outpatient Care, 7500 Security Boulevard, Mail Stop C4–05–13, Baltimore, MD 21244–1850, phone (410) 786–4709. Information can also be obtained by contacting the CMS Advisory Committees’ Information Line at 1–877–449–5659 (toll free) and (410) 786–9379 (local). SUPPLEMENTARY INFORMATION: I. Background The Secretary of the Department of Health and Human Services (the Secretary) is required by section 1833(t)(9)(A) of the Social Security Act (the Act) (42 U.S.C. 1395l(t)(9)(A)) and section 222 of the Public Health Service Act (PHS Act) (42 U.S.C. 217a) to consult with an expert outside advisory panel on the clinical integrity of the Ambulatory Payment Classification groups and weights. The Advisory Panel on Hospital Outpatient Payment (HOP, the Panel) is governed by the provisions of the Federal Advisory Committee Act (FACA) (Pub. L. 92–463, as amended (5 U.S.C. Appendix 2), which sets forth standards for the formation and use of advisory panels. The Panel Charter provides that the Panel shall meet up to 3 times annually. We consider the technical advice provided by the Panel as we prepare the proposed and final rules to update the outpatient prospective payment system for the next calendar year. The Panel shall consist of a chair and up to 19 members who are full-time employees of hospitals, hospital systems, or other Medicare providers. The Secretary or a designee selects the Panel membership based upon either self-nominations or nominations submitted by Medicare providers and other interested organizations. New appointments are made in a manner that ensures a balanced membership under the FACA guidelines. The Panel presently consists of the following members and a Chair: (The asterisk [*] indicates a Panel member whose term expires on July 31, 2012). • Edith Hambrick, M.D., J.D., Chair, CMS Medical Officer. • Ruth L. Bush, M.D., M.P.H. • Kari S. Cornicelli, C.P.A., FHFMA. • Dawn L. Francis, M.D., M.H.S. • Kathleen Graham, R.N., M.S.H.A.* PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 9255 • David A. Halsey, M.D. • Brian D. Kavanagh, M.D., MPH. • Judith T. Kelly, R.H.I.T., R.H.I.A., C.C.S. • Scott Manaker, M.D., Ph.D. • John Marshall, CRA, RCC, CIRCC, RT(R), FAHRA. • Jacqueline Phillips. • Randall A. Oyer, M.D. • Daniel J. Pothen, M.S., RHIA, CHPS. • Gregory Przybylski, M.D. • Marianna V. Spanaki-Varela, MD, Ph.D., M.B.A. II. Provisions of the Notice We published a notice in the Federal Register on November 25, 2011, entitled ‘‘Medicare Program; Renaming and Other Changes to the Advisory Panel on Hospital Outpatient Payment Charter (Formerly the Advisory Panel on Ambulatory Payment Classification Groups) and Request for Nominations’’ (76 FR 72708). The notice requested nominations to be added to the Panel by replacing one Panel member whose term expires on July 31, 2012; replacing one Panel member who resigned; and by adding four new Panel members (two of these designated as Critical Access Hospital representatives (see the November 30, 2011 final rule, (76 FR 74363)) to address appropriate supervision level for hospital outpatient services. As a result of that November 25, 2012 notice and the November 30, 2011 final rule, we are announcing six new members to the Panel. Their appointments are for 4-year terms commencing on February 1, 2012 and August 1, 2012. New Appointments to the Panel—The new members of the Panel with terms beginning on February 1, 2012 and continuing through January 31, 2016 are as follows: • Lanny Copeland, M.D., • Jim Nelson, • Leah Osbahr, • Traci Rabine; and • Gale Walker The new member of the Panel with a term beginning on August 1, 2012, and continuing through July 31, 2016 is: • Karen Borman, M.D. III. Collection of Information Requirements This document does not impose information collection and recordkeeping requirements. Consequently, it need not be reviewed by the Office of Management and Budget under the authority of the Paperwork Reduction Act of 1995 (44 U.S.C. 35). (Catalog of Federal Domestic Assistance Program; No. 93.773 Medicare—Hospital Insurance Program; and No. 93.774, E:\FR\FM\16FEN1.SGM 16FEN1

Agencies

[Federal Register Volume 77, Number 32 (Thursday, February 16, 2012)]
[Notices]
[Pages 9254-9255]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-3587]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Board on Radiation and Worker Health (ABRWH or Advisory 
Board), National Institute for Occupational Safety and Health (NIOSH)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), and pursuant to the requirements of 42 
CFR 83.15(a), the Centers for Disease Control and Prevention (CDC), 
announces the following meeting of the aforementioned committee:
    Board Public Meeting Times and Dates (All times are Pacific Time): 
9:45 a.m.-5 p.m., February 28, 2012. 8:15 a.m.-6 p.m., February 29, 
2012.
    Public Comment Times and Dates (All times are Pacific Time): 5 
p.m.-6:30 p.m.,* February 28, 2012.
    * Please note that the public comment periods may end before the 
times indicated, following the last call for comments. Members of the 
public who wish to provide public comments should plan to attend public 
comment sessions at the start times listed.
    Place: Waterfront Hotel, 10 Washington Street, Oakland, California 
94607, Telephone: (510) 836-3800, Fax: (510) 832-5695, Audio Conference 
Call via FTS Conferencing, the USA toll-free number is 1-866-659-0537 
with a pass code of 9933701.
    Status: Open to the public, limited only by the space available. 
The meeting space accommodates approximately 150 people.
    Background: The Advisory Board was established under the Energy 
Employees Occupational Illness Compensation Program Act of 2000 to 
advise the President on a variety of policy and technical functions 
required to implement and effectively manage the new compensation 
program. Key functions of the Advisory Board include providing advice 
on the development of probability of causation guidelines which have 
been promulgated by the Department of Health and Human Services (HHS) 
as a final rule, advice on methods of dose reconstruction which have 
also been promulgated by HHS as a final rule, advice on the scientific 
validity and quality of dose estimation and reconstruction efforts 
being performed for purposes of the compensation program, and advice on 
petitions to add classes of workers to the Special Exposure Cohort 
(SEC).
    In December 2000, the President delegated responsibility for 
funding, staffing, and operating the Advisory Board to HHS, which 
subsequently delegated this authority to the CDC. NIOSH implements this 
responsibility for CDC. The charter was issued on August 3, 2001, 
renewed at appropriate intervals, and will expire on August 3, 2013.
    Purpose: This Advisory Board is charged with (a) providing advice 
to the Secretary, HHS, on the development of guidelines under Executive 
Order 13179; (b) providing advice to the Secretary, HHS, on the 
scientific validity and quality of dose reconstruction efforts 
performed for this program; and (c) upon request by the Secretary, HHS, 
advise the Secretary on whether there is a class of employees at any 
Department of Energy facility who were exposed to radiation but for 
whom it is not feasible to estimate their radiation dose, and on 
whether there is reasonable likelihood that such radiation doses may 
have endangered the health of members of this class.
    Matters To Be Discussed: The agenda for the Advisory Board meeting 
includes: NIOSH Program Update; Department of Labor (DOL) Program 
Update; Department of Energy (DOE) Program Update; NIOSH 10-Year 
Program Review Implementation; Status of Activities for Lawrence 
Berkeley National Laboratory and Stanford Linear Accelerator; SEC 
petitions for: Electro Metallurgical (Niagara Falls, NY), Hangar 481 
(Kirtland Air Force Base); Weldon Spring Plant (Weldon Spring, MO), 
Sandia National Laboratories, Clinton Engineering Works (Oak Ridge, 
TN), Feed Materials Production Center (Fernald, Ohio), and Brookhaven 
National Laboratory; SEC Petition Status Updates; and Board Work 
Sessions.
    The agenda is subject to change as priorities dictate.
    In the event an individual cannot attend, written comments may be 
submitted in accordance with the redaction policy provided below. Any 
written comments received will be provided at the meeting and should be 
submitted to the contact person below well in advance of the meeting.
    Policy on Redaction of Board Meeting Transcripts (Public Comment): 
(1) If a person making a comment gives his or her name, no attempt will 
be made to redact that name. (2) NIOSH will take reasonable steps to 
ensure that individuals making public comment are aware of the fact 
that their comments (including their name, if provided) will appear in 
a transcript of the meeting posted on a public Web site. Such 
reasonable steps include: (a) A statement read at the start of each 
public comment period stating that transcripts will be posted and names 
of speakers will not be redacted; (b) A printed copy of the statement 
mentioned in (a) above will be displayed on the table where individuals 
sign up to make public comments; (c) A statement such as outlined in 
(a) above will also appear with the agenda for a Board Meeting when it 
is posted on the NIOSH Web site; (d) A statement such as in (a) above 
will appear in the Federal Register Notice that announces Board and 
Subcommittee meetings. (3) If an individual in making a statement 
reveals personal information (e.g., medical information) about 
themselves that information will not usually be redacted. The NIOSH 
FOIA coordinator will, however, review such revelations in accordance 
with the Freedom of Information Act and the Federal Advisory Committee 
Act and if deemed appropriate, will redact such information. (4) All 
disclosures of information concerning third parties will be redacted. 
(5) If it comes to the attention of the DFO that an individual wishes 
to share information with the Board but objects to doing so in a public 
forum, the Designated Federal Officer will work with that individual, 
in accordance with the Federal Advisory Committee Act, to find a way 
that the Board can hear such comments.
    Contact Person for More Information: Theodore Katz, M.P.A., 
Executive Secretary, NIOSH, CDC, 1600 Clifton Road NE., MS E-20, 
Atlanta, Georgia 30333, Telephone: (513) 533-6800, toll

[[Page 9255]]

free: 1-800-CDC-INFO, email: dcas@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

    Dated: February 7, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2012-3587 Filed 2-15-12; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.